Pembrolizumab vs chemotherapy in elderly patients with NSCLC: A comparative analysis of survival and adverse effects.

Authors: Fayaz Khan, Godbless Ajenaghughrure, Muayad Alzamara, Brian Patrick Singeltary

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20528

Source: Full article

---

Abstract

e20528